Skandinaviska Enskilda Banken AB publ Sells 2,246 Shares of Waters Co. (NYSE:WAT)
Skandinaviska Enskilda Banken AB publ trimmed its stake in Waters Co. (NYSE:WAT) by 13.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,624 shares of the medical instruments supplier’s stock after selling 2,246 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in Waters were worth $2,662,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in WAT. Pearl River Capital LLC purchased a new stake in Waters during the 1st quarter valued at $36,000. Sullivan Bruyette Speros & Blaney LLC purchased a new stake in shares of Waters in the fourth quarter valued at $104,000. CSat Investment Advisory L.P. boosted its stake in shares of Waters by 186.4% during the 4th quarter. CSat Investment Advisory L.P. now owns 653 shares of the medical instruments supplier’s stock worth $153,000 after purchasing an additional 425 shares during the period. Signaturefd LLC boosted its stake in shares of Waters by 299.4% during the 1st quarter. Signaturefd LLC now owns 679 shares of the medical instruments supplier’s stock worth $124,000 after purchasing an additional 509 shares during the period. Finally, Verus Capital Partners LLC bought a new position in Waters during the 4th quarter valued at about $161,000. Hedge funds and other institutional investors own 94.95% of the company’s stock.
Shares of NYSE:WAT opened at $176.62 on Tuesday. The company has a current ratio of 2.41, a quick ratio of 1.79 and a debt-to-equity ratio of 11.40. The company has a market capitalization of $10.82 billion, a PE ratio of 20.27, a P/E/G ratio of 5.40 and a beta of 0.96. Waters Co. has a 12-month low of $154.39 and a 12-month high of $245.68. The business’s fifty day simple moving average is $189.69 and its 200-day simple moving average is $204.32.
WAT has been the topic of a number of analyst reports. Bank of America cut their target price on Waters from $160.00 to $145.00 and set an “underperform” rating on the stock in a research note on Wednesday, April 29th. UBS Group reduced their target price on Waters from $223.00 to $212.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 28th. Wells Fargo & Co decreased their target price on Waters from $210.00 to $180.00 and set an “underweight” rating for the company in a research report on Monday, March 30th. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a report on Thursday, April 2nd. Finally, Needham & Company LLC initiated coverage on shares of Waters in a report on Tuesday, April 28th. They set a “sell” rating for the company. Five equities research analysts have rated the stock with a sell rating and six have given a hold rating to the company. Waters has a consensus rating of “Hold” and an average price target of $180.11.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Article: What is meant by a buy rating?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.